Methotrexate-biologic combo gives improved outcomes in early RA

Pooled data from 13 studies shows better scores with combination therapy
Reuters Health
Doctor examining hadn of woman with RA

The combination of methotrexate with a biologic provides better outcomes than methotrexate monotherapy in adults with early rheumatoid arthritis, a study shows.

US researchers conducted a systematic review of 22 randomised controlled trials, including nearly 10,000 participants who had been diagnosed with RA for a year or less.